Investment in later stage clinical development is needed to back up recent improvements in the discovery of new antibiotics, and to ensure the use of novel products is managed to maintain their effectiveness
UK science campaigner Mike Galsworthy, depleted after losing his all-consuming campaign to keep UK in the EU, says he has found a new fighting purpose for 2020
A new report by the European Commission says forcing foreign businesses to share their technologies in exchange for market access is a “systemic problem” in China
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.